Several possible studies
Story checked
Inside the global business of ‘three-parent IVF’ | A STAT investigation | STAT (opens in a new tab)
statnews.com · 2026-11-02
Short answer
Several possible studiesStudy not confirmed.
Several potential source studies were identified, but no single match could be confirmed. The article's claims remain unverified.
These papers were considered as possible sources, but none could be confirmed as the study behind this story.
Share this check
The story
Inside the global business of ‘three-parent IVF’ | A STAT investigation | STAT
statnews.com · 2026-11-02
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Multiple potential source studies identified.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
View article claimsSearch result
Several studies could fit.
Several studies match details in the article, but none could be confirmed as its source. The claims have not been assessed against a source study.
Evidence layer
Claim by claim
The article's claims are listed below. Without a confirmed source study, they have not been assessed as supported or unsupported.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 4Not checkedA pioneering IVF technique developed to reduce the risk of children inheriting sometimes-fatal mitochondrial diseases from their mothers is being marketed online as a fertility procedure for older women, despite scant evidence it works.View evidenceHide evidence
As statedscant evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 2 of 4Not checkedThe procedure, popularly called “three-parent IVF,” is illegal in the United States, but an Illinois-based company has facilitated a sprawling for-profit tourism industry, connecting women in the U.S. and Europe to clinics abroad.View evidenceHide evidence
As statedsprawling
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 3 of 4Not checkedSTAT’s investigation found examples of shoddy record keeping by a clinic providing the procedure, incomplete data published in marginal journals, and in one case, a puzzling ancestry test result that called into question the source of a child’s DNA.View evidenceHide evidence
As statedincomplete data
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Claim 4 of 4Not checkedThe technique, known as mitochondrial replacement techniques (MRT), was originally developed to spare children from rare inherited mitochondrial diseases, but more recently has been marketed as a solution for age-related fertility issues despite scant evidence of safety or efficacy for infertility treatment.View evidenceHide evidence
As statedscant evidence
Not checked
No source study was confirmed for this article. This claim remains unverified, rather than assessed as supported or unsupported.
Method layer
Study not confirmed.
The search results are available for you to inspect. Without a confirmed source study, they cannot establish whether the story’s claims are supported or contradicted.
Search results
Candidate papers, not confirmed sources.
PubMed, Europe PMC, Crossref · 15 candidate papers
Adipose Stem Cell Mitochondrial Transplantation in ART: From Biological Rationale to Clinical Milestone.
Cells · 2026 · PubMed, Europe PMC
Mild Ovarian Stimulation has Similar Live Birth Rates as Compared with Hyper Stimulation for Treatment of Poor Responding IVF Patients of Advanced Maternal Age
Journal of Fertility Biomarkers · 2017 · Crossref
Novel Approaches in Addressing Ovarian Insufficiency in 2019: Are We There Yet?
Cell Transplantation · 2020 · PubMed
Does preimplantation genetic testing for aneuploidy really improve IVF outcomes in advanced maternal age patients without compromising cumulative live-birth rate?
Journal of Assisted Reproduction and Genetics · 2020 · Crossref
Add-On Technologies That Aim to Improve Oocyte Quality and Embryo Implantation Potential.
2025 · Europe PMC